Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goodman-Meza

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
The International Journal on Drug Policy|August 31, 2025
High variation in purity of consumer-level illicit fentanyl samples in Los Angeles, September 2023-April 2025Chelsea L Shover, Adam J Koncsol, Morgan E Godvin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
High Variation in Purity of Consumer-Level Illicit Fentanyl Samples in Los Angeles, 2023-2025Chelsea L Shover, Adam J Koncsol, Morgan E Godvin, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Harm Reduction Journal|June 24, 2023
Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, MexicoPablo Gonzalez-Nieto, Anabel Salimian, Jaime Arredondo, et al.
Substance Use & Addiction Journal|February 6, 2025
Substance Use Disorder and Harm Reduction Curriculum in United States and Canadian Undergraduate Medical Education: An Online SurveyTucker Avra, Andrew Nelson, Joseph Friedman, et al.
Harm Reduction Journal|January 17, 2026
Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility studyWilliam Bradford, Daniel Dye, Rebecca Jensen, et al.
Open Forum Infectious Diseases|July 17, 2025
Sensitivity and Specificity of Natural Language Processing Systems for Identification of Hospitalized People Who Use DrugsLeah Benrubi, Taisuke Sato, Leo K Westgard, et al.
Heart, Lung & Circulation|February 13, 2016
Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection FractionMohammad Khalid Mojadidi, Jose Nahun Galeas, David Goodman-Meza, et al.
Clinical Microbiology Reviews|June 13, 2025
Bacterial and fungal infections in persons who inject drugsJeffrey Masters, David Goodman-Meza, Danielle Russell, et al.
The Lancet. Public Health|January 31, 2021
Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance dataDavid Goodman-Meza, Joseph Friedman, Mariah M Kalmin, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The International Journal on Drug Policy|August 31, 2025
High variation in purity of consumer-level illicit fentanyl samples in Los Angeles, September 2023-April 2025Chelsea L Shover, Adam J Koncsol, Morgan E Godvin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
High Variation in Purity of Consumer-Level Illicit Fentanyl Samples in Los Angeles, 2023-2025Chelsea L Shover, Adam J Koncsol, Morgan E Godvin, et al.
Journal of Substance Use and Addiction Treatment|May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing codeGayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Harm Reduction Journal|June 24, 2023
Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, MexicoPablo Gonzalez-Nieto, Anabel Salimian, Jaime Arredondo, et al.
Substance Use & Addiction Journal|February 6, 2025
Substance Use Disorder and Harm Reduction Curriculum in United States and Canadian Undergraduate Medical Education: An Online SurveyTucker Avra, Andrew Nelson, Joseph Friedman, et al.
Harm Reduction Journal|January 17, 2026
Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility studyWilliam Bradford, Daniel Dye, Rebecca Jensen, et al.
Open Forum Infectious Diseases|July 17, 2025
Sensitivity and Specificity of Natural Language Processing Systems for Identification of Hospitalized People Who Use DrugsLeah Benrubi, Taisuke Sato, Leo K Westgard, et al.
Heart, Lung & Circulation|February 13, 2016
Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection FractionMohammad Khalid Mojadidi, Jose Nahun Galeas, David Goodman-Meza, et al.
Clinical Microbiology Reviews|June 13, 2025
Bacterial and fungal infections in persons who inject drugsJeffrey Masters, David Goodman-Meza, Danielle Russell, et al.
The Lancet. Public Health|January 31, 2021
Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance dataDavid Goodman-Meza, Joseph Friedman, Mariah M Kalmin, et al.
Pageof 9